109 related articles for article (PubMed ID: 1081658)
21. Colony inhibition mediated by nonimmune leukocytes in vitro and skin reactivity in vivo as indices of tumorigenicity of guinea pig cultures transformed by chemical carcinogens.
Evans CH; Cooney AM; DiPaolo JA
Cancer Res; 1975 Apr; 35(4):1045-52. PubMed ID: 1116143
[TBL] [Abstract][Full Text] [Related]
22. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen.
Konda S; Nakao Y; Smith RT
Cancer Res; 1973 Oct; 33(10):2247-56. PubMed ID: 4147496
[No Abstract] [Full Text] [Related]
23. Problems in the use of in vitro assays for monitoring cell-mediated immunity in cancer patients.
de Vries JE
Bull Cancer; 1976; 63(2):279-86. PubMed ID: 791397
[TBL] [Abstract][Full Text] [Related]
24. [Recent data on the immunology of tumors. Mechanisms of escape of immunological control. Role of suppressor cells].
Lespinats G; Poupon MF
Bull Cancer; 1976; 63(2):269-78. PubMed ID: 1086690
[TBL] [Abstract][Full Text] [Related]
25. Loss of cell surface material from peritoneal exudate cells associated with lymphocyte-mediated inhibition of macrophage migration from capillary tubes.
Dvorak AM; Hammond ME; Dvorak HF; Karnovsky MJ
Lab Invest; 1972 Dec; 27(6):561-74. PubMed ID: 4118460
[No Abstract] [Full Text] [Related]
26. [New understanding of immunologic control mechanisms of tumor growth].
Sjögren HO
Schweiz Med Wochenschr; 1972 Aug; 102(33):1152-4. PubMed ID: 4341122
[No Abstract] [Full Text] [Related]
27. Termination of natural tolerance to alpha-foetoprotein in rats: study of cell-mediated immunity in the macrophage migration inhibition test.
Yazova A; Suslov AP; Brondz BD
Folia Biol (Praha); 1979; 25(2):81-94. PubMed ID: 88377
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of lymphocyte endothelial adhesion and in vivo lymphocyte migration to cutaneous inflammation by TA-3, a new monoclonal antibody to rat LFA-1.
Issekutz TB
J Immunol; 1992 Nov; 149(10):3394-402. PubMed ID: 1358970
[TBL] [Abstract][Full Text] [Related]
29. Migration inhibition of peritoneal exudate cells from sensitized and desensitized rats.
Jokiph L
Immunology; 1973 Aug; 25(2):283-95. PubMed ID: 4733804
[TBL] [Abstract][Full Text] [Related]
30. Dose-response relationship in the migration inhibition test using peritoneal exudate cells and blood leucocytes of tuberculin sensitive guinea pigs.
Sabioncello A; Dekaris D
Biomedicine; 1977 Dec; 26(6):399-403. PubMed ID: 606302
[TBL] [Abstract][Full Text] [Related]
31. Effect of tumor growth on migratory properties of T lymphocytes in rats.
Klobusická M; Koníková E; Novotná L
Neoplasma; 1980; 27(6):675-82. PubMed ID: 6973097
[TBL] [Abstract][Full Text] [Related]
32. An antigenic determinant of cytotoxic lymphocytes.
Sullivan KA; Berke G; Amos DB
Transplantation; 1973 Oct; 16(4):388-91. PubMed ID: 4126790
[No Abstract] [Full Text] [Related]
33. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). II. Analysis of the cytotoxic lymphocytes induced by OK-432 injection into tumor-bearing F344 rats.
Fukui H; Reynolds CW
J Natl Cancer Inst; 1987 Nov; 79(5):1019-24. PubMed ID: 3500354
[TBL] [Abstract][Full Text] [Related]
34. PHA skin test-correlation with migration inhibition but not with peripheral blood lymphocytes (PBL) subpopulations. With 1 figure.
Szczylik C; Wiktor-Jedrzejczak W
Allerg Immunol (Leipz); 1981; 27(3):162-7. PubMed ID: 6214937
[TBL] [Abstract][Full Text] [Related]
35. Study of cell-mediated immunity in B77 tumor bearing rats by 51chromium release assay.
Kalafut F; Novotná L; Valentová N
Neoplasma; 1981; 28(6):689-95. PubMed ID: 7339497
[TBL] [Abstract][Full Text] [Related]
36. Cell-mediated immune response of in vitro sensitized lymphocytes to isogeneic methyl-cholanthrene-induced tumor cell lines.
Warnatz H; Scheiffarth F
Transplantation; 1974 Sep; 18(3):273-9. PubMed ID: 4417443
[No Abstract] [Full Text] [Related]
37. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.
Nelson DL; Bundy BM; Pitchon HE; Blaese RM; Strober W
J Immunol; 1976 Nov; 117(5 Pt 1):1472-81. PubMed ID: 1087314
[TBL] [Abstract][Full Text] [Related]
38. Changes in the host lymphocyte subsets during chemical carcinogenesis.
Brodt P; Lala PK
Cancer Res; 1983 Sep; 43(9):4315-22. PubMed ID: 6871866
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxic activity of lymphocytes from patients with Hodgkin's disease.
Holm G; Björkholm M; Mellstedt H; Johansson B
Clin Exp Immunol; 1975 Sep; 21(3):376-83. PubMed ID: 1081933
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of T cell-mediated cytolysis by monoclonal antibodies directed against Lyt-2: heterogeneity of inhibition at the clonal level.
MacDonald HR; Thiernesse N; Cerottini JC
J Immunol; 1981 May; 126(5):1671-5. PubMed ID: 6452474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
